fluconazole has been researched along with laminaran in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 6 (75.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirakawa, K; Horiike, S; Kashima, K; Kuzuyama, Y; Misawa, S; Nakai, H; Seryu, T; Takashima, T; Taniwaki, M; Tsuda, S | 1 |
| Kusanagi, H; Shimura, T; Teramoto, A | 1 |
| Maesaki, S; Yamaguchi, T | 1 |
| Imamura, Y; Kakehashi, M; Kouyama, M; Morifuji, M; Murakami, Y; Ohge, H; Sasaki, M; Sueda, T; Takesue, Y; Yokoyama, T; Yokoyama, Y | 1 |
| Naito, Y | 1 |
| Andes, D; Hoff, B; Holoyda, K; Lincoln, L; Marchillo, K; Massey, R; Nett, J; VanHandel, M | 1 |
| del Palacio, A; Moragues, MD; Pazos, C; Pontón, J; Quindós, G | 1 |
| Luo, Z; Qiu, G; Zhang, Y; Zhao, D | 1 |
2 review(s) available for fluconazole and laminaran
| Article | Year |
|---|---|
[Candidiasis].
Topics: Antifungal Agents; beta-Glucans; Biomarkers; Candidiasis; Diagnosis, Differential; Echinocandins; Fluconazole; Glucans; Humans; Lipopeptides; Lipoproteins; Micafungin; Molecular Diagnostic Techniques; Peptides, Cyclic; Prognosis; Serologic Tests | 2003 |
[Emergent mycoses].
Topics: Amphotericin B; Antifungal Agents; beta-Glucans; Biomarkers; Disease Progression; Fatal Outcome; Fluconazole; Glucans; Humans; Immunocompromised Host; Male; Middle Aged; Mycoses; Otorhinolaryngologic Diseases; Risk Factors | 2004 |
2 trial(s) available for fluconazole and laminaran
| Article | Year |
|---|---|
[The usefulness of fluconazole administration and beta-D-glucan measurement in neurosurgical patients with deep-seated mycosis].
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; beta-Glucans; Biomarkers; Central Nervous System Fungal Infections; Fluconazole; Glucans; Humans; Middle Aged | 2000 |
Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anemia, Aplastic; Antibodies, Fungal; Antibody Specificity; Antifungal Agents; Antigens, Fungal; beta-Glucans; Candida albicans; Candidiasis; False Positive Reactions; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Hepatitis; Humans; Liposomes; Male; Middle Aged; Neutropenia; Patient Isolation; Predictive Value of Tests; Sensitivity and Specificity | 2006 |
4 other study(ies) available for fluconazole and laminaran
| Article | Year |
|---|---|
[Efficacy of fluconazole on systemic mycosis associated with hematologic malignancies and a study on diagnostic value of plasma beta-D-glucan levels].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; beta-Glucans; Biomarkers; Drug Evaluation; Female; Fluconazole; Glucans; Humans; Leukemia; Lymphoma; Male; Middle Aged; Mycoses | 1993 |
Combined assessment of beta-D-glucan and degree of candida colonization before starting empiric therapy for candidiasis in surgical patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Ascomycota; beta-Glucans; Candidiasis; Female; Fluconazole; Glucans; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Patient Selection; Postoperative Complications; Predictive Value of Tests; Prospective Studies; Treatment Outcome | 2004 |
Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.
Topics: Amphotericin B; Antifungal Agents; beta-Glucans; Biofilms; Candida albicans; Drug Resistance, Fungal; Fluconazole; Glucan 1,3-beta-Glucosidase; Microbial Sensitivity Tests | 2007 |
Platelet parameters and (1, 3)-β-D-glucan as a diagnostic and prognostic marker of invasive fungal disease in preterm infants.
Topics: beta-Glucans; Biomarkers; Blood Platelets; Case-Control Studies; Female; Fluconazole; Humans; Infant, Newborn; Infant, Premature; Male; Mean Platelet Volume; Mycoses; Platelet Count; Prognosis; ROC Curve; Sensitivity and Specificity; Sepsis | 2015 |